Risk of hepatitis C after immunoadsorption.
An episode of acute hepatitis in a patient with hemophilia during immunoadsorption therapy initially was misinterpreted as a reactivated hepatitis C virus (HCV) infection, but ultimately was shown to be an exogenous reinfection during cohort treatment with another HCV-positive patient. This incident illustrates that policies for the prevention of nosocomial transmission of blood-borne pathogens, especially in cohort treatment units, may need to be reassessed.
Kaiser
Rolf
R
Institute of Medical Microbiology and Immunology, University of Bonn, Germany.
Geulen
Oliver
O
Matz
Bertfried
B
Brackmann
Hans H
HH
Spengler
Ulrich
U
Kramer
Michael H
MH
Exner
Martin
M
Nettekoven
Wilhelm
W
Ko
You-Dschun
YD
Zeitler
Heike
H
Vetter
Hans
H
D000208:Acute Disease; D003428:Cross Infection; D004866:Equipment Contamination; D006467:Hemophilia A / Q000628:therapy*; D006526:Hepatitis C / Q000635:transmission*; D006801:Humans; D007163:Immunosorbent Techniques / Q000295:instrumentation*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors